Want to see LH full AI Analyst Report?

Labcorp Holdings (LH) Stock Forecast & Price Target

1,169 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

LH Analyst Ratings

Strong Buy

9 Buy

3 Hold

0 Sell

Based on 12 analysts giving stock ratings to

Labcorp

Holdings

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

LH Stock 12 Month Forecast

Average Price Target

$335.09

▲(12.91% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Labcorp Holdings in the last 3 months. The average price target is $335.09 with a high forecast of $361.00 and a low forecast of $306.00. The average price target represents a 12.91% change from the last price of $296.77.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"248":"$248","305":"$305","362":"$362","276.5":"$276.5","333.5":"$333.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":361,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$361.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":335.09090909090907,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$335.09</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":306,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$306.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[248,276.5,305,333.5,362],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,309.2,313.18461538461537,317.16923076923075,321.15384615384613,325.1384615384615,329.1230769230769,333.10769230769233,337.0923076923077,341.0769230769231,345.0615384615385,349.04615384615386,353.03076923076924,357.0153846153846,{"y":361,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,309.2,311.1916083916084,313.1832167832168,315.1748251748252,317.16643356643357,319.15804195804196,321.14965034965036,323.1412587412587,325.1328671328671,327.1244755244755,329.1160839160839,331.1076923076923,333.09930069930067,{"y":335.09090909090907,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,309.2,308.95384615384614,308.7076923076923,308.46153846153845,308.2153846153846,307.96923076923076,307.7230769230769,307.4769230769231,307.2307692307692,306.9846153846154,306.73846153846154,306.4923076923077,306.24615384615385,{"y":306,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":258.767,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":275.796,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":276.857,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":251.956,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":266.328,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":249.566,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":268.874,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":285.685,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":271.992,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":255.138,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":256.87,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":283.88,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":309.2,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$361.00

Average Price Target$335.09

Lowest Price Target$306.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

David Westenberg

Piper Sandler

$300→$309

Hold

4.12%

Upside

Reiterated

08/04/26

Piper Sandler Remains a Hold on Labcorp Holdings (LH)

Lisa Gill

J.P. Morgan

$330→$360

Buy

21.31%

Upside

Assigned

08/03/26

Labcorp price target raised to $360 from $330 at JPMorganLabcorp price target raised to $360 from $330 at JPMorgan

Erin Wright

Morgan Stanley

$308→$338

Buy

13.89%

Upside

Reiterated

07/31/26

Morgan Stanley Sticks to Their Buy Rating for Labcorp Holdings (LH)

David S Macdonald

Truist Financial

$320→$350

Buy

17.94%

Upside

Reiterated

07/31/26

Truist Financial Sticks to Their Buy Rating for Labcorp Holdings (LH)

Eric Coldwell

Robert W. Baird

$338→$352

Buy

18.61%

Upside

Reiterated

07/31/26

Labcorp price target raised to $352 from $338 at BairdLabcorp price target raised to $352 from $338 at Baird

Pito Chickering

Deutsche Bank

$276→$306

Hold

3.11%

Upside

Assigned

07/31/26

Labcorp price target raised to $306 from $276 at Deutsche BankLabcorp price target raised to $306 from $276 at Deutsche Bank

Luke Sergott

Barclays

$290→$320

Hold

7.83%

Upside

Reiterated

07/31/26

Labcorp price target raised to $320 from $290 at BarclaysLabcorp price target raised to $320 from $290 at Barclays

Kevin Caliendo

UBS

$320→$361

Buy

21.64%

Upside

Reiterated

07/31/26

UBS Remains a Buy on Labcorp Holdings (LH)

Michael Ryskin

Bank of America Securities

$320→$360

Buy

21.31%

Upside

Reiterated

07/30/26

Labcorp: Guidance Raised, Biopharma Momentum Strengthens, and Price Target Increased to $360 on Higher FY27 EBITDA Multiple

Jared Haase

William Blair

―

Buy

―

Reiterated

07/30/26

Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (NYSE: LH) and Cytokinetics (NASDAQ: CYTK)

David Toung

Argus Research

$310

Buy

4.46%

Upside

Reiterated

06/02/26

Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (NYSE: LH), Moderna (NASDAQ: MRNA) and Celcuity (NASDAQ: CELC)

Unknown Analyst

Mizuho Securities

Not Ranked

Mizuho Securities

$320

Buy

7.83%

Upside

Reiterated

05/27/26

Labcorp Holdings (LH) Gets a Buy from Mizuho Securities

Elizabeth Anderson CFA

Evercore ISI

$300

Buy

1.09%

Upside

Reiterated

05/01/26

Evercore ISI Keeps Their Buy Rating on Labcorp Holdings (LH)

Patrick B Donnelly

Citi

$325

Buy

9.51%

Upside

Reiterated

01/02/26

Analysts' Top Healthcare Picks: Doximity (DOCS), Labcorp Holdings (LH)

Michael Cherny

Leerink Partners

$323→$342

Buy

15.24%

Upside

Reiterated

10/08/25

Leerink Partners Reaffirms Their Buy Rating on Labcorp Holdings (LH)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

David Westenberg

Piper Sandler

$300→$309

Hold

4.12%

Upside

Reiterated

08/04/26

Piper Sandler Remains a Hold on Labcorp Holdings (LH)

Lisa Gill

J.P. Morgan

$330→$360

Buy

21.31%

Upside

Assigned

08/03/26

Labcorp price target raised to $360 from $330 at JPMorganLabcorp price target raised to $360 from $330 at JPMorgan

Erin Wright

Morgan Stanley

$308→$338

Buy

13.89%

Upside

Reiterated

07/31/26

Morgan Stanley Sticks to Their Buy Rating for Labcorp Holdings (LH)

David S Macdonald

Truist Financial

$320→$350

Buy

17.94%

Upside

Reiterated

07/31/26

Truist Financial Sticks to Their Buy Rating for Labcorp Holdings (LH)

Eric Coldwell

Robert W. Baird

$338→$352

Buy

18.61%

Upside

Reiterated

07/31/26

Labcorp price target raised to $352 from $338 at BairdLabcorp price target raised to $352 from $338 at Baird

Pito Chickering

Deutsche Bank

$276→$306

Hold

3.11%

Upside

Assigned

07/31/26

Labcorp price target raised to $306 from $276 at Deutsche BankLabcorp price target raised to $306 from $276 at Deutsche Bank

Luke Sergott

Barclays

$290→$320

Hold

7.83%

Upside

Reiterated

07/31/26

Labcorp price target raised to $320 from $290 at BarclaysLabcorp price target raised to $320 from $290 at Barclays

Kevin Caliendo

UBS

$320→$361

Buy

21.64%

Upside

Reiterated

07/31/26

UBS Remains a Buy on Labcorp Holdings (LH)

Michael Ryskin

Bank of America Securities

$320→$360

Buy

21.31%

Upside

Reiterated

07/30/26

Labcorp: Guidance Raised, Biopharma Momentum Strengthens, and Price Target Increased to $360 on Higher FY27 EBITDA Multiple

Jared Haase

William Blair

―

Buy

―

Reiterated

07/30/26

Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (NYSE: LH) and Cytokinetics (NASDAQ: CYTK)

David Toung

Argus Research

$310

Buy

4.46%

Upside

Reiterated

06/02/26

Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (NYSE: LH), Moderna (NASDAQ: MRNA) and Celcuity (NASDAQ: CELC)

Unknown Analyst

Mizuho Securities

Not Ranked

Mizuho Securities

$320

Buy

7.83%

Upside

Reiterated

05/27/26

Labcorp Holdings (LH) Gets a Buy from Mizuho Securities

Elizabeth Anderson CFA

Evercore ISI

$300

Buy

1.09%

Upside

Reiterated

05/01/26

Evercore ISI Keeps Their Buy Rating on Labcorp Holdings (LH)

Patrick B Donnelly

Citi

$325

Buy

9.51%

Upside

Reiterated

01/02/26

Analysts' Top Healthcare Picks: Doximity (DOCS), Labcorp Holdings (LH)

Michael Cherny

Leerink Partners

$323→$342

Buy

15.24%

Upside

Reiterated

10/08/25

Leerink Partners Reaffirms Their Buy Rating on Labcorp Holdings (LH)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

AMLXAmylyx Pharmaceuticals Inc

TNYATenaya Therapeutics

JBIOJade Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Labcorp Holdings

3 Months

Erin WrightMorgan Stanley

Success Rate

17/23 ratings generated profit

Average Return

+5.04%

Copying Erin Wright's trades and holding each position for 3 Months would result in 73.91% of your transactions generating a profit, with an average return of +5.04% per trade.

1 Year

Lisa GillJ.P. Morgan

Success Rate

13/13 ratings generated profit

Average Return

+17.46%

Copying Lisa Gill's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +17.46% per trade.

2 Years

Erin WrightMorgan Stanley

Success Rate

23/23 ratings generated profit

Average Return

+28.87%

Copying Erin Wright's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +28.87% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

LH Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, LH has received 9 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. LH average Analyst price target in the past 3 months is 335.09.

Each month's total comprises the sum of three months' worth of ratings.

LH Financial Forecast

LH Earnings Forecast

Next quarter’s earnings estimate for LH is $4.65 with a range of $4.49 to $4.73. The previous quarter’s EPS was $4.99. LH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 46.32% of the time in the same period. In the last calendar year LH has Performed in-line its overall industry.

LH Sales Forecast

Next quarter’s sales forecast for LH is $3.76B with a range of $3.74B to $3.78B. The previous quarter’s sales results were $3.73B. LH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 31.16% of the time in the same period. In the last calendar year LH has Performed in-line its overall industry.

LH Stock Forecast FAQ

What is LH’s average 12-month price target, according to analysts?

Based on analyst ratings, Labcorp Holdings’s 12-month average price target is 335.09.

What is LH’s upside potential, based on the analysts’ average price target?

Labcorp Holdings has 12.91% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is LH a Buy, Sell or Hold?

Labcorp Holdings has a consensus rating of Strong Buy which is based on 9 buy ratings, 3 hold ratings and 0 sell ratings.

What is Labcorp Holdings’s price target?

The average price target for Labcorp Holdings is 335.09. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $361.00 ,the lowest forecast is $306.00. The average price target represents 12.91% Increase from the current price of $296.77.

What do analysts say about Labcorp Holdings?

Labcorp Holdings’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of LH?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Labcorp Holdings (LH) Stock Forecast & Price Target

LH Analyst Ratings

LH Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Labcorp Holdings

LH Analyst Recommendation Trends

LH Financial Forecast

LH Earnings Forecast

LH Sales Forecast

LH Stock Forecast FAQ

Detailed List of Analyst Forecasts